+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Absorption, distribution, metabolism, and excretion of N-octylbicycloheptene dicarboximide (MGK 264) administered orally to rats



Absorption, distribution, metabolism, and excretion of N-octylbicycloheptene dicarboximide (MGK 264) administered orally to rats



Journal of Toxicology Cutaneous and Ocular Toxicology 18(4): 291-310



Experiments were conducted in four groups of rats to determine the absorption, distribution, metabolism, and excretion (ADME) patterns following oral administration of (hexyl-1-14C) N-octylbicycloheptene dicarboximide (MGK 264). Ten rats (five males and five females) were used in each of the four experiments. Fasted rats were administered (hexyl-1-14C) MGK 264 at a single oral dose of 100 mg/kg, at a single oral dose of 1000 mg/kg, and at a daily oral dose of 100 mg/kg of nonradiolabeled compound for 14 days followed by a single dose of 14C-labeled compound at 100 mg/kg. Rat blood kinetics were determined in the fourth group following a single oral dose of 100 mg/kg. Each animal was administered 18-30 muCi radioactivity. Urine and feces were collected for all groups at predetermined time intervals. Seven days after dose administration, the rats were euthanized and selected tissues and organs were harvested. Samples of urine, feces, and tissues were subsequently analyzed for 14C content. In the blood kinetics study, radioactivity peaked at approximately 4 h for the males and 6 h for the females. The decline of radioactivity from blood followed a monophasic elimination pattern. The half-life of blood radioactivity was approximately 8 h for males and 6 h for females. Female rats excreted 71.45-73.05% of the radioactivity in urine and 20.87-25.28% in feces, whereas male rats excreted 49.49-63.49% of the administered radioactivity in urine and 31.76-46.67% in feces. Total tissue residues of radioactivity at 7 days ranged from 0.13 to 0.43% of the administered dose for all dosage regimens. The only tissues with 14C residues consistently higher than that of plasma were the liver, stomach, intestines, and carcass. The total mean recovered radioactivity of the administered dose in the studies ranged between 93.1 and 97.4%. No parent compound was detected in the urine. Four major metabolites and one minor metabolite were isolated from the urine by high-performan ce liquid chromatography (HPLC) and identified by gas chromatography/mass spectometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS). The four major metabolites were shown to be carboxylic acids produced by either omega-1 oxidation or beta-oxidation of the side chain and oxidation of the norbornene ring double bond. The minor metabolite was the carboxylic acid of the intact norbornene ring. The gender of the animals affected the rate, route of excretion, and metabolic profile. The urinary excretion rate was faster in females than in males and the amount excreted was also greater in female rats.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010113245

Download citation: RISBibTeXText

DOI: 10.3109/15569529909065547


Related references

Absorption, distribution, metabolism, and excretion of N-octylbicycloheptene dicarboximide (MGK 264) administered dermally to rats. Journal of Toxicology Cutaneous and Ocular Toxicology 18(4): 311-323, 1999

Absorption distribution metabolism and excretion of orally administered carbon 14 procysteine in rats. Viii International Conference on Aids And The Iii Std World Congress Published Abstracts Submitted to The Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, 220p Viii International Congress And The Iii Std World Congress: Amsterdam, Netherlands Paper : 83, 1992

Metabolism of bile acids. IV. Absorption, distribution, excretion and metabolism of orally administered ursodeoxycholic acid in rats. Hiroshima Journal of Medical Sciences 26(4): 233-251, 1977

Metabolism of bile acids part 4 absorption distribution excretion and metabolism of orally administered ursodeoxy cholic acid in rats. Hiroshima Journal of Medical Sciences 26(4): 233-252, 1977

Absorption, distribution, metabolism and excretion of intravenously and orally administered tetrabromobisphenol A [2,3-dibromopropyl ether] in male Fischer-344 rats. Toxicology 237(1-3): 158-167, 2007

Studies on the fate of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FD-1), a new antitumor agent. I. Absorption, distribution, excretion and metabolism of FD-1 administered orally to rats. Yakugaku Zasshi 98(4): 525-536, 1978

Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat. Arzneimittel-Forschung 35(7): 1042-1047, 1985

Absorption, distribution in tissues and routes of excretion of preparation IF-ROM-196 administered to rats orally. Materia Medica Polona. Polish Journal of Medicine and Pharmacy 7(4): 304-307, 1975

The absorption distribution and excretion of orally administered barium 133 chloride in weanling male rats. Toxicology & Applied Pharmacology 29(1): 139, 1974

Intestinal absorption distribution and excretion of an orally administered polymeric anti oxidant in rats and mice. Food and Cosmetics Toxicology 16(4): 321-330, 1978

Pharmaco kinetics absorption distribution metabolism excretion of carbon 14 labeled sch 1000 ipratropium bromide administered by inhalation orally and intra venously. Postgraduate Medical Journal Suppl. 51(7): 93-94, 1975

Digestive absorption distribution and excretion of disulfiram administered orally in the rat. Archives Internationales de Pharmacodynamie et de Therapie 223(2): 339-350, 1976

Studies on the fate of 5 fluoro 1 3 bis tetrahydro 2 furanyl 2 4 pyrimidinedione a new anti tumor agent part 1 absorption distribution excretion and metabolism of 5 fluoro 1 3 bis tetrahydro 2 furanyl 2 4 pyrimidinedione administered orally to rats. Yakugaku Zasshi 98(4): 525-536, 1978

Absorption, metabolism, and excretion of intravenously and orally administered (14C)telmisartan in healthy volunteers. Journal of Clinical Pharmacology 40(12 Part 1): 1312-1322, 2000

Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers. Journal of Clinical Pharmacology 40(12 Pt 1): 1312-1322, 2000